After a weeklong review of safety data, the World Health Organization announced today that it’s ending a “pause” in the use of the antimalarial drug hydroxychloroquine in an international clinical trial of potential COVID-19 therapies.
After a weeklong review of safety data, the World Health Organization announced today that it’s ending a “pause” in the use of the antimalarial drug hydroxychloroquine in an international clinical trial of potential COVID-19 therapies.